Antiplatelet and Antithrombotic Therapy in Percutaneous Coronary Interventions

Amit Hooda; Gurpreet S. Johal; Usman Baber

doi:10.1007/978-3-030-68538-6_5

Antiplatelet and Antithrombotic Therapy in Percutaneous Coronary Interventions

Amit Hooda
, Gurpreet S. Johal
, Usman Baber

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Dual antiplatelet therapy (DAPT) is the cornerstone of pharmacological therapy preventing atherothrombotic complications. Advances in drug-eluting stent technology, antiplatelet pharmacotherapy, and novel parenteral and oral anticoagulants (OAC) have led to constant evolution in periprocedural antithrombotic strategy. The following chapter outlines our cardiac catheterization laboratory’s current approach to antiplatelet and anticoagulation therapy in various clinical settings based on current guidelines and expert opinion.

Original language	English
Title of host publication	Practical Manual of Interventional Cardiology
Subtitle of host publication	Second Edition
Publisher	Springer International Publishing
Pages	61-70
Number of pages	10
ISBN (Electronic)	9783030685386
ISBN (Print)	9783030685379
DOIs	https://doi.org/10.1007/978-3-030-68538-6_5
State	Published - 1 Jan 2021

Keywords

Antiplatelet therapy
Cangrelor
DAPT
DOAC
Oral anticoagulant
P2Y12 inhibitor
Platelet count
VKA

Access to Document

10.1007/978-3-030-68538-6_5

Cite this

@inbook{ecd45ca3000f4ca39df8ce95c1c9cbbb,

title = "Antiplatelet and Antithrombotic Therapy in Percutaneous Coronary Interventions",

abstract = "Dual antiplatelet therapy (DAPT) is the cornerstone of pharmacological therapy preventing atherothrombotic complications. Advances in drug-eluting stent technology, antiplatelet pharmacotherapy, and novel parenteral and oral anticoagulants (OAC) have led to constant evolution in periprocedural antithrombotic strategy. The following chapter outlines our cardiac catheterization laboratory{\textquoteright}s current approach to antiplatelet and anticoagulation therapy in various clinical settings based on current guidelines and expert opinion.",

keywords = "Antiplatelet therapy, Cangrelor, DAPT, DOAC, Oral anticoagulant, P2Y12 inhibitor, Platelet count, VKA",

author = "Amit Hooda and Johal, \{Gurpreet S.\} and Usman Baber",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2014, 2021.",

year = "2021",

month = jan,

day = "1",

doi = "10.1007/978-3-030-68538-6\_5",

language = "English",

isbn = "9783030685379",

pages = "61--70",

booktitle = "Practical Manual of Interventional Cardiology",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Antiplatelet and Antithrombotic Therapy in Percutaneous Coronary Interventions

AU - Hooda, Amit

AU - Johal, Gurpreet S.

AU - Baber, Usman

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2014, 2021.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Dual antiplatelet therapy (DAPT) is the cornerstone of pharmacological therapy preventing atherothrombotic complications. Advances in drug-eluting stent technology, antiplatelet pharmacotherapy, and novel parenteral and oral anticoagulants (OAC) have led to constant evolution in periprocedural antithrombotic strategy. The following chapter outlines our cardiac catheterization laboratory’s current approach to antiplatelet and anticoagulation therapy in various clinical settings based on current guidelines and expert opinion.

AB - Dual antiplatelet therapy (DAPT) is the cornerstone of pharmacological therapy preventing atherothrombotic complications. Advances in drug-eluting stent technology, antiplatelet pharmacotherapy, and novel parenteral and oral anticoagulants (OAC) have led to constant evolution in periprocedural antithrombotic strategy. The following chapter outlines our cardiac catheterization laboratory’s current approach to antiplatelet and anticoagulation therapy in various clinical settings based on current guidelines and expert opinion.

KW - Antiplatelet therapy

KW - Cangrelor

KW - DAPT

KW - DOAC

KW - Oral anticoagulant

KW - P2Y12 inhibitor

KW - Platelet count

KW - VKA

UR - https://www.scopus.com/pages/publications/85170171830

U2 - 10.1007/978-3-030-68538-6_5

DO - 10.1007/978-3-030-68538-6_5

M3 - Chapter

AN - SCOPUS:85170171830

SN - 9783030685379

SP - 61

EP - 70

BT - Practical Manual of Interventional Cardiology

PB - Springer International Publishing

ER -

Antiplatelet and Antithrombotic Therapy in Percutaneous Coronary Interventions

Abstract

Keywords

Access to Document

Fingerprint

Cite this